Maximum Views Reached

You have reached the maximum number of Guideline views for today. By creating a free account, you can increase your number of complimentary daily views.

To view this Guideline, please log in to your account. If you do not have an account, you can create one for free by clicking the button below.

Combined Hormonal Contraception And The Risk Of Venous Thromboembolism

Publication Date: January 1, 2017

Last Updated: March 14, 2022

Summary

High-dose combined oral contraception (>50 μg) is associated with higher risks of VTE than lower-dose formulations. (, B)

340025

Recommendation

In the patient in whom combined hormonal contraception is appropriate, it is reasonable to use any currently available preparation. (, )

Combined Hormonal Contraception And The Risk Of Venous Thromboembolism

Summary

Recommendation

Overview

Title

Authoring Organization